US Drug Recall Register
Class II · Moderate risk Terminated Initiated Jan 19, 2017 (10 years ago)

glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Tablets/Capsules; bottles of Glipizide 5 mg tablets may contain Glipizide 10 mg tablets

What was recalled

glipiZIDE Extended-Release Tablets, 5 mg, 1000 count bottles, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV --- NDC 0378-0342-10

Recalling firm
Mylan Pharmaceuticals Inc.
NDC code
0378-0342-10
Origin
WV, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0491-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glipizide recalls

See all